Paydirt
ED
Insider

Edmund Dunn

Principal Accounting Officer

Edmund Dunn (Principal Accounting Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Monte Rosa Therapeutics, Inc. (GLUE). The largest single filing was $455K of GLUE (25,164 sh × $18.10, as filed), executed Feb 27.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$455K
shares × price, as filed
Last traded
Feb 27
Filed Mar 2

Median ADV $21.1M across their filed names

Open performance
Volume by month
$455K$228K$0Oct 2024Apr 2025Oct 2025Apr 2026Mar 2026 · sells $455K
Buys $0 Sells $455K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
GLUE Monte Rosa Therapeutics, Inc. GLUE · 0 buys · 1 sell 1 filing
Recent filings
GLUESALE Monte Rosa Therapeutics, Inc. View filing → $455K
25,164 sh × $18.10
Exec Feb 27
Filed Mar 2 · 5:30 PM ET